Adoptive T cell therapies have markedly improved outcomes in hematologic malignancies but their efficacy in solid tumors can be diminished by a hostile tumor...

Daman et al. show that bladder administration of BCG, a microbial immunotherapy for bladder cancer, triggers a systemic immune response, reprogramming HSPCs and resulting in increased myeloid-driven a...